PET scanning with 18F 2-fluoro-2-deoxy-D-glucose (FDG) in patients with melanoma: Benefits and limitations

Clinical Positron Imaging (Netherlands)

Volumn 2, Issue 2, 1999, Pages 93-98

  Nguyen, An T ^a,b   Akhurst, Tim ^b   Larson, Steven M ^b   Coit, Daniel G ^b   Brady, Mary S ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

CT Scanning; Diagnosis; False Negative; False Positive; High Risk; Melanoma; PET; Recurrent; Surgery; True Negative; True Positive; Utility

Indexed keywords

EID: 0002566447     PISSN: 10950397     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1095-0397(99)00006-0     Document Type: Article

References (24)

1. S.L. Parker T. Tong S. Bolden Cancer statistics, 1997 Cancer J. Clin. 47 1997 5 27
2. J.D. Wagner D. Schauwecker G. Hutchins Initial assessment of positron emission tomography for detection of nonpalpable regional lymphatic metastases in melanoma J. Surg. Oncol. 64 1997 181 187
3. Kosary, C.L.; Ries, L.A.G.; Miller, B.A.; et al (eds). SEER Cancer Statistics Review, 1973-1992: Tables and Graphs. Bethesda, MD: National Cancer Institute, NIH Pub. No. 96-2789, 1995.
4. D.S. Rigel Malignant melanoma incidence issues and their effect on diagnosis and treatment in the 1990s Mayo Clin. Proc. 72 1997 367 371
5. L. Martini P. Brandani C. Chiarugi First recurrence analysis of 840 cutaneous melanomas a proposal for a follow-up schedule Tumori 80 1994 188 197
6. D.L. Morton D.G. Davtyan L.A. Wanek Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness Cancer 71 1993 3737 3743
7. M.A. Hena L.J. Emrich R.N. Nambisan Effect of surgical treatment of Stage IV melanoma Am. J. Surg. 153 1987 270 275
8. T.A. Huffman W.K. Sterin Ten-year survival with multiple metastatic malignant melanoma. Primary site unknown Arch. Surg. 106 1973 234 235
9. T.K. Overett M.H. Shiu Surgical treatment of distant metastatic melanoma Cancer 565 1985 1222 1230
10. I.L. Wornom J.W. Smith S.-J. Soong Surgery as palliative treatment for distant metastases of melanoma Ann. Surgery 204 1986 181 185
11. D.L. Damian M.J. Fulham E. Thompson Positron emission tomography in the detection and management of metastatic melanoma Mel. Res. 6 1996 325 329
12. C.P. Karakousis A. Veleg D.L. Driscoll Metastasectomy in malignant melanoma Surgery 115 1994 295 302
13. J.H. Wong K.A. Skinner K.A. Kim The role of surgery in the treatment of non-regionally recurrent melanoma Surgery 113 1993 389 394
14. L.S. Gritters I.R. Francis K.R. Zasadny Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy- d -glucose in the imaging of malignant melanoma J. Nucl. Med. 34 1993 1420 1427
15. H.C. Steinert R.A.H. Boni A. Buck Malignant melanoma staging with whole body positron emission tomography and 20[F-18]-fluoro-2-deoxy- d -glucose Radiology 195 1995 705 709
16. L.G. Strauss A. Dimitrakopoulou-Strauss G. van Kaick Pet studies with F-18-deoxyglucose in patients with metastatic melanoma prior and after therapy J. Nucl. Med. 35 1994 38P
17. C. Blessing U. Feine L. Geiger Positron emission tomography and ultrasonography a comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanoma Arch. Dermatol. 131 1995 1394 1398
18. M. Bhattathiry E. Glass D. Kirgan Efficacy of FDG whole-body PET in staging and clinical management of metastatic malignant melanoma J. Nucl. Med. 35 1994 230P
19. D. Kirgan J. Guenther M. Bhattathiry The importance of whole body PET scans on the management of metastatic malignant melanoma Prog. Proc. Annu. Meet. Am. Soc. Clin. Oncol. 13 1994 396
20. W.J. Yao C.K. Hoh J.A. Glaspy Whole-body FDG PET imaging for staging of malignant melanoma is it cost effective? J. Nucl. Med. 35 1994 8P
21. 18F-fluorodeoxyglucose positron emission tomography results of a prospective study of 100 patients Cancer 82 1998 1664 1671
22. Fleming, I.D.; Cooper, J.S.; Henson, D.E.; et al, eds. AJCC Cancer Staging Manual. New York: Lippincott-Raven, 1997.
23. G. Larcos M.N. Massey FDG-PET screening for cerebral metastases in patients with suspected malignancy Nucl. Med. Comm. 17 1996 197 198
24. N.J. Patronas G. Di Chiro C. Kufta Prediction of survival in glioma patients by means of positron emission tomography J. Neurosurg. 62 1985 816 822